Maroun Chedid

Cardiology and Advanced Heart Failure Fellow @HCMC_MHIfellows | Research Associate @MHIF_Heart| via @LebaneseUni, Post-Doc Fellowship @MayoClinic| 🇱🇧 in 🇺🇸

[Maroun Chedid @MarounCh3]

Decannulation from Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock does not equate recovery! Check our recent paper highlighting the increased mortality risk even following ECMO decannulation. https://t.co/dVTeg9deAV
@DrKevinBuda @MHIF_Heart @asaiojournal

[Maroun Chedid @MarounCh3]

Early bioprosthetic valve deterioration after TAVR is more common than thought (14%). Anticoagulation may protect; HALT flags risk. Early BVD → earlier mortality, HF admissions, and redo TAVR. Check out our paper @CJCJournals @MHIF_Heart @MHIValveDoc

https://t.co/YPfjnnzPPi

[CJC Journals @CJCJournals]

🔓 For a limited time until December 31, we are offering free promotional access to this new article in #CJC! 🌐
Early bioprosthetic valve deterioration after TAVR is more common than thought (14%). Anticoagulation may protect; HALT flags risk. Early BVD → earlier mortality, HF admissions, and redo TAVR.
Read more ⬇️
https://t.co/K8KWl8bml5

[Maroun Chedid @MarounCh3]

Does MAC severity affect patient outcomes following aortic valve replacement? Our recent publication showed no effect on MR/MS severity or death following AVR across MAC severity
@CRT_meeting @MHIF_Heart @MHIValveDoc

https://t.co/o6EHgeMzy1

[Maroun Chedid @MarounCh3]

Anthracycline cardio toxicity can appear at any time after exposure. Check out our case of delayed cardio toxicity mimicking ARVC in a young athlete!
@JACCJournals @MHIF_Heart

https://t.co/Xr5A1nG29H

[ZOLL Cardiac Management Solutions @zoll_cms]

🚨 Now published in European Heart Journal (SCD-PROTECT): High SCA treatment rate despite contemporary GDMT in 19,500 consecutive LifeVest (NICM and MI/CAD) patients, confirming importance of SCD protection during initiation of GDMT.

[Valerio Capraro @ValerioCapraro]

Fascinating paper just published in Science.

The authors analyze the career trajectories of top performers across multiple domains, including Nobel laureates, elite chess players, Olympic gold medalists, and more.

Their central finding challenges a common belief.

Intensive, single-discipline training at a young age does confer an early advantage, but this advantage fades over time.

By contrast, individuals exposed to multidisciplinary practice early in life tend to start more slowly. Yet, over the long run, they are more likely to reach world-class performance, eventually overtaking early specialists, who often plateau just below the very top.

An important reminder that breadth early on can be a powerful investment in long-term excellence.

Link to the paper in the first reply.

[Pope Leo XIV @Pontifex]

I was deeply moved by my brief visit to the Port of Beirut, where an explosion devastated not just the area, but many human lives. I prayed for all the victims, and I carry with me the pain and thirst for truth and justice of so many families, of an entire country. #ApostolicJourney #Lebanon

[Pope Leo XIV @Pontifex]

#Lebanon will flourish once again, beautiful and vigorous like the cedar, a symbol of the people’s unity and fruitfulness. The strength of the cedar lies in its roots. In the same way, the many good things we see in Lebanese society today are the result of the humble, hidden and honest work of so many people of good will, of the many good roots. Draw from the good roots of those dedicated to serving society. Be the source of hope that the country is waiting for! #ApostolicJourney

[Circulation @CircAHA]

#AHA25 Continuous RV monitoring reveals immediate hemodynamic response to Sotatercept in PAH. https://t.co/prP0rnMZf3 @PullamsettiL

[Maroun Chedid @MarounCh3]

@drkeithsiau Mees Lines- Arsenic poisoning/chemotherapy

[Benoy Shah MD @dr_benoy_n_shah]

Deep dive on #EARLYTAVR from ##TCT2024

Lots already said & discussed

It takes time to read the paper, read the supplementary appendix, analyse the results, think about them etc!

Some thoughts...🧵

[Maroun Chedid @MarounCh3]

@OungSavly Ebstein’s anomaly, especially with the very large P waves in V2!

[Muthu Vaduganathan @mvaduganathan]

🚨#FLOW: The most anticipated trial of the year now published in @NEJM with #ERA24

Semaglutide 1.0mg once weekly disease modifying with kidney, CV, & mortality benefits in people w T2D+CKD, cementing itself as a new pillar of care.

🧵 on key thoughts 👇🏾

https://t.co/5fbSxPSAMM

[Maroun Chedid @MarounCh3]

Check out our most recent work, regarding Polymorphic VT and VF in patients with Takotsubo Syndrome!
@hcmcim

[Dr. Kevin Buda @DrKevinBuda]

Awesome work led by @MarounCh3 with @hcmcim in @AmJCardio 🔥🔥🔥 Among 296 patients meeting InterTAK criteria for stress cardiomyopathy:
👉🏼 9.1% had polymorphic VT or VF
👉🏼 apical-variant, a history of substance use disorder, and EF <30% were associated with a higher risk of PVT/VF
⚠️ The first six hours is an especially high-risk period for PVT/VF, and 100% of life-threatening tachyarrhythmias occurred in the first 24 hours.

Full article: https://t.co/bKy4iOrggL

@HCMC_MHIfellows @HennepinHC @HennepinHC_GME @MHIF_Heart

[Ziad Zoghby, MD, MBA, FACP @ZiZoghby]

Check the EHR-integrated application that our team developed to streamline care for #ADPKD patients enrolled in our #Tolvaptan clinic. https://t.co/NVtTFUkh3f @MayoClinicNeph @fouadchebib @MarounCh3

[NEJM @NEJM]

Presented today at #ACC24:

In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: https://t.co/3625asvzu8

[Maroun Chedid @MarounCh3]

@ecgandrhythmRoe Typical anticlockwise atrial flutter. Possibly atrial tachycardia since atrial rate around 200 ?

[Maroun Chedid @MarounCh3]

@ecgandrhythmRoe VT (capture and fusion beats, AV dissociation). In setting of known ICM VT is the most likely dx. Plus 150 bpm is relatively slow for pre-excited A fib.

[Maroun Chedid @MarounCh3]

@AaronGoodman33 The best @Dr_AbdulMD